Sharon Chapman

1.3k total citations
22 papers, 1.0k citations indexed

About

Sharon Chapman is a scholar working on Molecular Biology, Epidemiology and Biochemistry. According to data from OpenAlex, Sharon Chapman has authored 22 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Epidemiology and 5 papers in Biochemistry. Recurrent topics in Sharon Chapman's work include Herpesvirus Infections and Treatments (4 papers), Polyamine Metabolism and Applications (4 papers) and Amino Acid Enzymes and Metabolism (3 papers). Sharon Chapman is often cited by papers focused on Herpesvirus Infections and Treatments (4 papers), Polyamine Metabolism and Applications (4 papers) and Amino Acid Enzymes and Metabolism (3 papers). Sharon Chapman collaborates with scholars based in United States and United Kingdom. Sharon Chapman's co-authors include Michael S. Saag, Marilyn M. Helms, Lawrence P. Ettkin, Thom J. Zimmerman, T. H. Maren, Gillian Reid, Barry Quart, George W. Yu, Neil J. Clendeninn and William G. Powderly and has published in prestigious journals such as New England Journal of Medicine, Biochemical Journal and Ophthalmology.

In The Last Decade

Sharon Chapman

22 papers receiving 936 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sharon Chapman United States 17 310 215 212 191 135 22 1.0k
Haishan Li United States 19 138 0.4× 373 1.7× 239 1.1× 159 0.8× 13 0.1× 32 1.4k
Anther Keung United States 14 193 0.6× 310 1.4× 178 0.8× 76 0.4× 8 0.1× 24 948
Martin J. McDermott United States 21 167 0.5× 440 2.0× 706 3.3× 309 1.6× 6 0.0× 50 1.3k
Steven Lacy United States 19 346 1.1× 134 0.6× 333 1.6× 72 0.4× 16 0.1× 29 1.2k
Kaili Wang China 23 163 0.5× 108 0.5× 388 1.8× 16 0.1× 37 0.3× 83 1.4k
Gurinder Singh India 19 44 0.1× 52 0.2× 202 1.0× 27 0.1× 363 2.7× 52 1.5k
J. H. Beijnen Netherlands 17 133 0.4× 100 0.5× 320 1.5× 73 0.4× 6 0.0× 40 797
Patricia A. McKernan United States 19 218 0.7× 225 1.0× 440 2.1× 30 0.2× 3 0.0× 33 1.2k
Michele Connelly United States 30 486 1.6× 661 3.1× 1.6k 7.7× 319 1.7× 17 0.1× 66 3.1k
Ruonan Zhang China 18 88 0.3× 37 0.2× 590 2.8× 57 0.3× 7 0.1× 60 1.1k

Countries citing papers authored by Sharon Chapman

Since Specialization
Citations

This map shows the geographic impact of Sharon Chapman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon Chapman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon Chapman more than expected).

Fields of papers citing papers by Sharon Chapman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon Chapman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon Chapman. The network helps show where Sharon Chapman may publish in the future.

Co-authorship network of co-authors of Sharon Chapman

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon Chapman. A scholar is included among the top collaborators of Sharon Chapman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon Chapman. Sharon Chapman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saag, Michael S., Pablo Tebas, Michael Sension, et al.. (2001). Randomized, double-blind comparison of two nelfinavir doses plus nucleosides in HIV-infected patients (Agouron study 511). AIDS. 15(15). 1971–1978. 51 indexed citations
2.
Helms, Marilyn M., Lawrence P. Ettkin, & Sharon Chapman. (2000). Supply chain forecasting – Collaborative forecasting supports supply chain management. Business Process Management Journal. 6(5). 392–407. 89 indexed citations
3.
Powderly, William G., Michael S. Saag, Sharon Chapman, et al.. (1999). Predictors of optimal virological response to potent antiretroviral therapy. AIDS. 13(14). 1873–1880. 150 indexed citations
4.
5.
Moore, Geoffrey R., et al.. (1992). Isolation and characterization of the cytochrome domain of flavocytochrome b2 expressed independently in Escherichia coli. Biochemical Journal. 283(1). 87–90. 26 indexed citations
6.
Leventhal, Brigid G., Haskins K. Kashima, Phoebe Mounts, et al.. (1991). Long-Term Response of Recurrent Respiratory Papillomatosis to Treatment with Lymphoblastoid Interferon Alfa-N1. New England Journal of Medicine. 325(9). 613–617. 96 indexed citations
7.
BLACK, M., et al.. (1989). Structural basis for the kinetic differences between flavocytochromes b2 from the yeasts Hansenula anomala and Saccharomyces cerevisiae. Biochemical Journal. 263(3). 973–976. 29 indexed citations
8.
Bubley, Glenn J., Brooke Chapman, Sharon Chapman, Clyde S. Crumpacker, & Lowell E. Schnipper. (1989). Effect of acyclovir on radiation- and chemotherapy-induced mouth lesions. Antimicrobial Agents and Chemotherapy. 33(6). 862–865. 33 indexed citations
9.
BLACK, M., Scott A. White, Gillian Reid, & Sharon Chapman. (1989). High-level expression of fully active yeast flavocytochrome b2 in Escherichia coli. Biochemical Journal. 258(1). 255–259. 45 indexed citations
10.
Goldberg, Leonard H., et al.. (1986). Oral acyclovir for episodic treatment of recurrent genital herpes. Journal of the American Academy of Dermatology. 15(2). 256–264. 33 indexed citations
11.
Cobo, L. Michael, Gary N. Foulks, Thomas J. Liesegang, et al.. (1985). Oral Acyclovir in the Therapy of Acute Herpes Zoster Ophthalmicus. Ophthalmology. 92(11). 1574–1583. 46 indexed citations
12.
Ross, Warren E., et al.. (1981). Cytotoxicity and deoxyribonucleic acid damage associated with bromoacetate. Biochemical Pharmacology. 30(12). 1497–1500. 4 indexed citations
13.
Chapman, Sharon. (1980). Antitumor effects of vitamin A and inhibitors of ornithine decarboxylase in cultured neuroblastoma and glioma cells. Life Sciences. 26(16). 1359–1366. 22 indexed citations
14.
Chapman, Sharon, et al.. (1980). Antiproliferative effects of inhibitors of polyamine synthesis in tumors of neural origin. Journal of Pharmaceutical Sciences. 69(6). 733–735. 6 indexed citations
15.
Chapman, Sharon & Thomas H. Maren. (1978). A search for the function of human carbonic anhydrase B. Biochimica et Biophysica Acta (BBA) - Enzymology. 527(1). 272–276. 9 indexed citations
16.
Chapman, Sharon, et al.. (1978). A study of serum folate by high-performance ion-exchange and ion-pair partition chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 145(2). 302–306. 29 indexed citations
17.
Chapman, Sharon, et al.. (1978). Ornithine decarboxylase activity and the growth of neuroblastoma cells. Biochemical Pharmacology. 27(5). 717–721. 20 indexed citations
18.
Maren, T. H., et al.. (1977). The pharmacology of methazolamide in relation to the treatment of glaucoma.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 16(8). 730–42. 109 indexed citations
19.
Chapman, Sharon. (1976). Polyamines and drug oxidations.. Drug Metabolism and Disposition. 4(5). 417–422. 10 indexed citations
20.
Chapman, Sharon & Kenneth C. Leibman. (1971). The effects of chlordane, DDT, and 3-methylcholanthrene upon the metabolism and toxicity of diethyl-4-nitrophenyl phosphorothionate (Parathion). Toxicology and Applied Pharmacology. 18(4). 977–987. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026